Covered recipient · General Payments record
ROHITH JESUDAS
Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology
General Payments · PY2018–2024
$15,574.70
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $11,675.00 | 3 |
| Travel and Lodging | $1,280.68 | 4 |
| Food and Beverage | $361.14 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $10,266.82 | 8 |
| Merck Sharp & Dohme Corporation | $3,050.00 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GENZYME CORPORATION | $121.83 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139723551 | CMS |
| GENZYME CORPORATION | $224.23 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139723615 | CMS |
| GENZYME CORPORATION | $15.08 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139723617 | CMS |
| GENZYME CORPORATION | $219.70 | 09/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139723619 | CMS |
| GENZYME CORPORATION | $613.68 | 09/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139723621 | CMS |
| GENZYME CORPORATION | $429.30 | 09/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139723623 | CMS |
| GENZYME CORPORATION | $18.00 | 09/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139723625 | CMS |
| GENZYME CORPORATION | $8,625.00 | 09/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139723627 | CMS |
| Merck Sharp & Dohme LLC | $1,830.00 | 01/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141681741 | CMS |
| Merck Sharp & Dohme LLC | $1,220.00 | 05/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141598920 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.